IRIS
GAETA, Giovanni Battista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.935
NA - Nord America 9.480
AS - Asia 5.703
SA - Sud America 1.087
Continente sconosciuto - Info sul continente non disponibili 312
AF - Africa 87
OC - Oceania 10
Totale 31.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.225
RU - Federazione Russa 8.990
SG - Singapore 2.128
IE - Irlanda 1.789
CN - Cina 1.319
HK - Hong Kong 1.033
UA - Ucraina 977
BR - Brasile 919
GB - Regno Unito 816
IT - Italia 731
DE - Germania 549
VN - Vietnam 474
SE - Svezia 293
FI - Finlandia 279
GR - Grecia 175
IN - India 170
TR - Turchia 151
FR - Francia 138
CA - Canada 115
KR - Corea 106
JP - Giappone 70
AR - Argentina 67
BD - Bangladesh 66
BE - Belgio 35
MX - Messico 32
CZ - Repubblica Ceca 30
IQ - Iraq 30
ID - Indonesia 28
EC - Ecuador 24
AT - Austria 23
IR - Iran 22
NL - Olanda 22
PL - Polonia 21
PK - Pakistan 19
PY - Paraguay 19
HN - Honduras 17
ZA - Sudafrica 17
CR - Costa Rica 15
EU - Europa 15
VE - Venezuela 15
EG - Egitto 14
JM - Giamaica 13
MA - Marocco 13
TT - Trinidad e Tobago 13
CO - Colombia 12
NI - Nicaragua 12
RO - Romania 12
TW - Taiwan 11
CL - Cile 9
DO - Repubblica Dominicana 9
PE - Perù 9
TH - Thailandia 9
AU - Australia 8
EE - Estonia 8
GT - Guatemala 8
UZ - Uzbekistan 8
DZ - Algeria 7
ES - Italia 7
ET - Etiopia 7
PH - Filippine 7
PR - Porto Rico 7
UY - Uruguay 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CW - ???statistics.table.value.countryCode.CW??? 5
JO - Giordania 5
LT - Lituania 5
SV - El Salvador 5
BB - Barbados 4
GH - Ghana 4
IL - Israele 4
NP - Nepal 4
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HU - Ungheria 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
SA - Arabia Saudita 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BF - Burkina Faso 2
BH - Bahrain 2
CY - Cipro 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
AM - Armenia 1
Totale 31.302
Salva come PNG Salva come JPEG
Città #
Moscow 3.225
Dublin 1.783
Jacksonville 1.405
Hong Kong 1.021
Chandler 894
Santa Clara 779
Singapore 750
San Jose 725
Ashburn 702
Council Bluffs 501
Dallas 317
Princeton 291
Medford 236
Beijing 184
Ho Chi Minh City 162
Milan 162
Boardman 158
Roxbury 140
San Mateo 130
Wilmington 123
Ann Arbor 108
Hanoi 105
Hefei 105
Seoul 104
Bengaluru 97
New York 93
The Dalles 86
Woodbridge 84
Munich 79
Bremen 77
Cambridge 72
São Paulo 65
Los Angeles 61
Nanjing 61
Des Moines 55
Miano 53
Düsseldorf 47
Helsinki 47
Rome 44
Mountain View 40
Jinan 36
Orem 35
Brussels 34
Caserta 30
Atlanta 29
Naples 28
Brno 27
Nanchang 27
Rio de Janeiro 27
Venice 27
Memphis 26
Da Nang 25
Haiphong 25
Napoli 25
Zhengzhou 25
Shanghai 24
Belo Horizonte 22
Guangzhou 22
Norwalk 22
Shenyang 22
Brasília 19
Frankfurt am Main 19
Tokyo 19
Changsha 18
Nuremberg 18
Tianjin 18
Turku 18
Campinas 17
Chennai 17
Curitiba 17
Kunming 17
North Bergen 17
Chicago 16
Porto Alegre 16
Hangzhou 14
Houston 14
San José 13
Toronto 13
Montreal 12
Ningbo 12
Ninh Bình 12
Ottawa 12
Recife 12
Baghdad 11
Brooklyn 11
Dhaka 11
Redwood City 11
Santo André 11
Guayaquil 10
Haikou 10
Hebei 10
Hải Dương 10
Phoenix 10
Asunción 9
Auburn Hills 9
Istanbul 9
Kingston 9
Kraków 9
Managua 9
Miami 9
Totale 16.237
Salva come PNG Salva come JPEG
Nome #
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 487
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 359
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 316
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 310
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 195
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 188
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 186
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 186
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 184
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 176
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 175
AISF position paper on HCV in immunocompromised patients 171
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 169
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 168
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 166
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 166
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP) 163
AISF position paper on liver disease and pregnancy 162
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 160
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 159
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 157
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 156
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 154
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas 154
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 152
Changing indications for liver transplant: slow decline of hepatitis viruses in Italy 151
Virological patterns of HCV patients with failure to interferon-free regimens. 150
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 149
[Prevalence and risk factors for bacteriuria in patients with cirrhosis] 149
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 148
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 147
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 147
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 146
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 146
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 145
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 145
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B 142
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir 142
Clinical and histological aspects of chronic HCV infection and cirrhosis 141
[Cutaneous myiasis from Cordylobia anthropophaga in a traveller returning from Senegal: a case study] 140
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 139
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 139
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 138
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 138
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 138
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3 137
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. 137
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 136
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 136
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 136
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 136
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 135
Hepatitis delta infection in Italian patients: towards the end of the story? 134
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 133
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 133
[Visceral leishmaniasis: its epidemiology, clinical picture and therapy] 133
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 132
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 132
[Visceral leishmaniasis in Italy. Its epidemiology, clinical picture and therapy] 131
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 131
Fever of unknown origin: a systematic review of the literature for 1995-2004 130
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 130
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 130
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 129
Doctors in the kitchen. Experiments with cooking bivalve mollusks 129
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 129
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 129
Liver toxicity during copper chronic intoxication in rats 129
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 129
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 129
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 128
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 128
[Cryptosporidium infection in immunocompetent and immunocompromised host] 128
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 128
Functional changes induced by taurolithocolic acid in the isolated perfused rat liver 127
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 127
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 127
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 126
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 126
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 125
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 125
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 125
Hepatic excretory function in the endotoxin tolerant rat 125
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis 125
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 124
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 124
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 124
Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. 123
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 123
Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the study of the liver) 122
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study 121
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 120
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 120
Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts 119
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. 119
Interference of endotoxin pretreatment on the taurolithocholate induced cholestasis 118
Effect of chronic copper administration on excretory function of rat liver 118
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 118
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 117
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C 117
Totale 14.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.514 0 0 0 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/20241.143 113 34 51 110 438 75 10 35 4 25 57 191
2024/20253.550 58 53 34 102 502 309 582 308 526 622 263 191
2025/202614.292 407 516 929 762 1.133 8.376 689 351 552 268 204 105
2026/20272.618 99 414 1.049 1.056 0 0 0 0 0 0 0 0
Totale 31.614